Health

Since the start of this year, two curious new groups have been set up in Brussels: the Consumer Choice Center and an EU branch of the Freedom Organisation for the Right to Enjoy Smoking Tobacco (Forest EU). They claim to represent consumers, but a closer look shows no links to those they allege to speak for.

A combined effect of EU-level policies and corporate lobbying is creating a pro-privatisation environment for healthcare provision in Europe. Our new research explores the EU policy areas – and the role of corporate lobbying – that encourages more privatised models of healthcare: marketisation, trade, public private partnerships, and economic governance.

Next Tuesday, the European Parliament's employment committee will vote on a directive that, quite literally, is a life-and-death issue. On the table: the revision of EU laws to protect workers from cancer-causing substances at work.

Our new report shows how industry lobbies present employee protection against work-related cancers as an 'unnecessary' burden on companies, and explains which tactics have been used to weaken and delay the European Union's revision of the Carcinogens and Mutagens Directive.

CEO welcomes the very strongly worded final ruling by European Ombudsman Emily O’Reilly in her inquiry into the Commission’s implementation of UN rules for contacts with tobacco industry lobbyists.

A documentary program broadcast on Dutch TV last week has sparked major concerns about the health risks of playing football on artificial turf fields made with rubber granulate from old car tyres. Corporate lobbying seems to have been behind the lack of regulation of these surfaces used by thousands of children every week.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

On 15 June 2016, the Commission will finally announce the long-awaited scientific criteria for EDCs. Time to do a recap of this last season’s main episodes.

Splits occur within European Commission, as European Parliament, Ombudsman and NGOs increase the pressure for implementing UN rules for contacts with tobacco industry lobbyists.

2 to 10 times more pharma lobby meetings took place below the Commission's top levels disclosed online.

Big money and close ties behind Big Pharma's Brussels lobby efforts – new study

Redactions speak louder than words.